Experts in the Treatment of Lymphomas

The Stanford Lymphoma Program is comprised of a dedicated core of individuals who have pioneered significant advances in the treatment of lymphoma. Members of this team are routinely recognized and awarded for their contributions to the treatment of lymphoma for both adults and children. 

Lymphoma Program
300pasteurdr-stanford
875 Blake Wilbur Drive
Palo Alto, CA 94304
Phone: 650-498-6000 Getting Here
Maps & Directions
875 Blake Wilbur Drive
Palo Alto, CA 94304
Phone: 650-498-6000 Getting Here

Our Doctors

Care and Treatment of Lymphomas

Clinical Research and Clinical Trials

Our patients benefit from treatment by experienced professionals who participate in the clinical trial development of promising new cancer treatments often not yet available at other facilities.

Current research

  • The development of rituximab, by Dr. Ronald Levy, the monoclonal anti-CD20 antibody, has changed the treatment of lymphoma worldwide. Stanford Cancer Center physicians and researchers discovered the therapeutic effects of this antibody and have been instrumental in developing its many applications.
  • Stanford researchers have validated that an expression of two genes together, one by tumor cells and another by the immune microenvironment, are extremely useful in predicting overall survival in patients with diffuse large B cell lymphoma (DLBCL), the most common form of non-Hodgkin's lymphoma. This finding could result in the first gene-based screen to identify patients who may benefit from immediate treatment with the most aggressive therapies.
  • We have led the development of novel targets therapies, such as the oral inhibitor of Bruton tyrosine kinase (Btk), a critical part of the signaling pathway required for B cell growth.

Clinical Trials

Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you have access to the latest, advanced clinical trials.

Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.

Before beginning treatment, ask your doctor about any clinical trials you should consider. Learn more about clinical trials for cancer patients.

Clinical trial eligibility flowcharts

Eligibility flowcharts map clinical trials to specific types of cancers to determine if a participant is eligible for the particular clinical trial. View all lymphoma eligibility flowcharts at the Stanford Cancer Institute.

For Patients

PREPARE FOR YOUR APPOINTMENT

Review the New Patient Packet for information about:

  • What to expect on the day of your appointment
  • Maps, directions, parking, public transit options, and contact information
  • Other patient resources

Bring completed forms found in the Lymphoma New Patient Letter.

MEDICAL RELEASE

Please fax the Medical Record Release Form to your new patient coordinator. The medical release form is an authorization form for external facilities to release medical records to Stanford Health Care (formerly Stanford Hospital & Clinics). 

International Patients
Phone: +1 650-723-8561
Email: IMS@stanfordmed.org

Call us to make an appointment

650-498-6000

For Health Care Professionals

PHYSICIAN HELPLINE

Phone: 1-866-742-4811
Fax: 650-320-9443
Monday – Friday, 8:30 a.m. – 5 p.m.

Stanford Health Care (formerly Stanford Hospital & Clinics) provides comprehensive services to refer and track patients, as well as provides the latest information and news for physicians and office staff. For help with all referral needs and questions visit Referring Physicians.

HOW TO REFER

Fax a referral form with supporting documentation to 650-320-9443.

Please note, though this form is from Stanford Health Care (formerly Stanford Hospital & Clinics), it is also used for all Cancer Center referrals.

Track your patients' progress and communicate with Stanford providers securely online.

Learn More About PRISM »